Market research on the Cannabis industry. Standardised and cross-...
Market research on the Cannabis industry. Standardised and cross-comparable statistics including total market and format sizes, cannabinoid content, distribution and industry trends and sub-category level information
Argentina faced an uncertain macroeconomic scenario due to political disfunction and economic instability, with one of the highest inflation rates in the world, although according to Comisión Económica para América Latina y Caribe (CEPAL), gross…
The number of users of medical cannabis in Australia continued to grow in 2023, driven by growing public acceptance of cannabis legalisation. More and more Australians are supportive of improving access to and the safety of medical cannabis through…
Cannabis in Belgium experienced continued rapid growth in 2023, primarily driven by CBD & other non-intoxicating cannabinoids, with the most popular format being CBD flower, followed by CBD oil (tinctures and sprays). Medical cannabis is also…
Contrary to expectations, the national government did not advance hemp legislation for medical and industrial purposes in 2023. Instead, it opted to sidestep a potentially contentious debate, prioritising a comprehensive tax reformulation on its…
Cannabis sales growth is being driven by adult-use cannabis, with a growing user base linked to the illicit market, growing social acceptance and fair pricing. Heightened consumer stress as a result for inflation is also encouraging growing use,…
The cannabis culture in Chile is at an intermediate stage of development compared to other countries in Latin America. Since decriminalisation of cannabis for medicinal use in 2016, Chile has witnessed an explosion in “grow shops” and home growing to…
Colombia, historically linked with drug trafficking, has undergone a noteworthy transformation by actively cultivating a well-regulated cannabis industry. The legalisation of medical cannabis, the establishment of a legal framework for licensed…
The approval of medical cannabis has been postponed again to 2024 according to official sources. However, it is estimated that its full implementation will be further delayed. France began its medical trial in 2021. It was set to be a 2-year pilot…
The so-called “traffic-light” coalition is attempting to revolutionise Germany’s drug policy. The current plan to legalise cannabis is, however, a rather cautious approach to that. Yet, the debate has shown how much cannabis is already part of many…
Since mid-2022, inflationary pressures and the decline in disposable incomes have had an impact on Cannabis product consumption in Greece. On the one hand, the cost of living crisis is taking its toll on consumer spending on Cannabis products. These…